MedTrace Logo

Anti-Obesity Effect of Pediococcus Pentosaceus LP28

NCT01685944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2016-02-26

No results posted yet for this study

Summary

This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

Conditions

Interventions

DIETARY_SUPPLEMENT

Live Pediococcus pentosaceus LP28

DIETARY_SUPPLEMENT

Heat-killed Pediococcus pentosaceus LP28

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Hiroshima University

    lead OTHER

Principal Investigators

  • Fumiko Higashikawa, PhD · Hiroshima University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01685944 on ClinicalTrials.gov